Vol. 2 No. 3 (2023) | Bleeding, Thrombosis and Vascular Biology

Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB

Current Issue

Vol. 2 No. 3 (2023)

31 July 2023

View this Issue

Impact Factor 2025

Vol. 2 No. 3 (2023)

Published: 31 July 2023

Editorials

Reducing the risks of nuclear war - The role of health professionals

Kamran Abbasi, Parveen Ali, Virginia Barbour, Kirsten Bibbins-Domingo, Marcel G.M. Olde Rikkert, Andy Haines, Ira Helfand, Richard Horton, Bob Mash, Arun Mitra, Carlos Monteiro, Elena N. Naumova, Eric J. Rubin, Tilman Ruff, Peush Sahni, James Tumwine, Paul Yonga, Chris Zielinski

https://doi.org/10.4081/btvb.2023.94

1398

PDF: 413
- PDF
Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

Paolo Prandoni

https://doi.org/10.4081/btvb.2023.97

2091

PDF: 430
- PDF
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

https://doi.org/10.4081/btvb.2023.91

1786

PDF: 544
- PDF

Reviews

Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond

Cristina Santoro, Alessandro Casini

https://doi.org/10.4081/btvb.2023.75

1690

PDF: 568
- PDF

Mini-reviews

Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

https://doi.org/10.4081/btvb.2023.90

2107

PDF: 787
- PDF

Original Articles

Restrained glycoprotein VI-induced platelet signaling by tyrosine protein phosphatases independent of phospholipase Cγ2

Jingnan Huang, Delia I. Fernández, Jinmi Zou, Xueqing Wang, Johan W.M. Heemskerk, Ángel García

https://doi.org/10.4081/btvb.2023.93

859

PDF: 349
- PDF
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

https://doi.org/10.4081/btvb.2023.92

1436

PDF: 454
- PDF
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

Mosaad Almegren

https://doi.org/10.4081/btvb.2023.85

1115

PDF: 330
- PDF
Platelet distribution width is associated with cardiovascular mortality in an adult general population

Benedetta Izzi, Simona Costanzo, Alessandro Gialluisi, Amalia De Curtis, Sara Magnacca, Teresa Panzera, Augusto Di Castelnuovo, Maria Benedetta Donati, Chiara Cerletti, Marc F. Hoylaerts, Giovanni de Gaetano, Licia Iacoviello, *on behalf of the Moli-sani Study Investigators

https://doi.org/10.4081/btvb.2023.83

3030

PDF: 483

Supplementary Material: 133
- PDF
- Supplementary Material

Case Reports

Importance of assessment of carotid plaques in the managementof acute ischemic stroke: floating intracarotid plaque

Marwa Eltemamy, Robert Namushi, Narayanamoorthi Saravanan

https://doi.org/10.4081/btvb.2023.79

1389

PDF: 377
- PDF

Letters to the Editor

What is the gender of thrombosis? A natural model of precision medicine

Rossella Marcucci, Rosanna Abbate

https://doi.org/10.4081/btvb.2023.87

1047

PDF: 456
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.